Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
8.195 USD | -2.21% | -0.24% | +25.85% |
04-30 | RBC Lifts Price Target on Avid Bioservices to $8 From $7, Keeps Outperform Rating | MT |
04-29 | Transcript : Avid Bioservices, Inc., Q3 2024 Earnings Call, Apr 29, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+25.85% | 532M | |
-3.35% | 88.91B | |
+2.76% | 41.25B | |
-14.59% | 31.99B | |
+50.51% | 24.73B | |
-15.00% | 15.54B | |
-39.93% | 12.07B | |
-9.08% | 12.05B | |
-15.30% | 12.02B | |
+6.22% | 8.84B |
- Stock Market
- Equities
- CDMO Stock
- News Avid Bioservices, Inc.
- Sector Update: Health Care